EGFR and non-small cell lung carcinoma: Another study from the University of Medicineand Pharmacy in Ho Chi Minh City, Vietnam, performed Sanger sequencing on 135samples and found EGFR mutations in 40.7%.27 In August 2015, researchers fromBach Mai Hospital, Hanoi, Vietnam, presented an abstract at a national oncologyconference showing that of 166 tested NSCLC samples at their hospital, 38.0% hadEGFR-activation mutations.